Advancing Black Talent in Pharma (ABTiP)
Diversity Initiative of the Year
Advancing Black Talent in Pharma (ABTiP) exemplifies what it means to foster real, sustainable change in the Canadian pharmaceutical and life sciences sector. By uniting a diverse coalition of organizations—including GSK, McGill University, Novo Nordisk, and others—ABTiP drives a mission to advance Black talent, increase accountability, and prioritize inclusivity across the industry.
Through a powerful, three-pillar approach focused on development, empowerment, and engagement, ABTiP creates targeted opportunities for Black professionals. Initiatives like mentorship circles, leadership development, and industry-specific workshops nurture talent, broaden career horizons, and actively work to dismantle industry barriers. The impact is clear: ABTiP promotes both career growth and a culture of inclusion, advancing real strides in representation.
A hallmark of ABTiP’s work is its commitment to transparency and open dialogue. By encouraging conversations on diversity, equity, and inclusion, ABTiP fosters a safe space for sharing experiences and receiving constructive feedback. This dedication to accountability has inspired leadership buy-in, embedding diversity as a core industry priority rather than a checkbox.
Through the 2024 Shine Bright Diversity Initiative of the Year Award, Women Leaders in Pharma proudly honors Advancing Black Talent in Pharma, celebrating its remarkable achievements in creating a more inclusive and representative industry.
The 2024 Shine Bright Diversity Initiative of the Year Award honors a non-profit initiative that has successfully engaged stakeholders, set clear goals, and achieved significant, measurable results. This award recognizes efforts that empower and engage women while actively reducing discrimination and exclusion based on ethnicity, race, sex, or age. It celebrates initiatives that foster inclusivity and create meaningful change within the community.